Navigation Links
Must-Haves for Your Summer Vacation Bag
Date:7/28/2009

s and brand names.

Transitions((R)) lenses are the ideal everyday choice for healthy sight. They are clear indoors and at night. Outdoors, they automatically darken as light conditions change. Transitions lenses provide visual comfort, and enhance visual quality by reducing glare and enhancing contrast, helping you to see better today. Transitions lenses block 100 percent of harmful UVA and UVB rays -- helping to protect the health and wellness of your eyes -- so you can see better tomorrow as well.

For more information about the company and Transitions lenses, the first to earn the American Optometric Association's Seal of Acceptance for Ultraviolet Absorbers/Blockers, visit Transitions.com or contact Transitions Optical Customer Service at (800) 848-1506 (United States) or (877) 254-2590 (Canada).

(1) American Cancer Society


'/>"/>
SOURCE Transitions Optical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. H1N1 Swine Flu Leads to Cancellation of HIV/AIDS Summer Camp. One Heartland Announces Campaign to Fund Alternative Camp Session for 82 Children.
2. Photos: Dont Let Them See You Sweat This Summer
3. May Institute, National Autism Center, and Automoblox Launch Cars for Classrooms Summer Charitable Campaign to Benefit Children with Autism
4. Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop
5. Amgen Scholars Discover Their Potential During Summer Science Research Program and National Symposium
6. Guard Against Swine Flu at Summer Camp
7. Hartfords Camp Courant Gets a Brick Up on Summer Thanks to $100,000 Grant From The LEGO(R) Childrens Fund
8. Fitness Gurus Warn Women Not To Give Up On Their Diet Just Because Summer Has Arrived
9. Looking to Shape Up for Summer? The Solution May Be the Steps Youre Already Taking
10. Spa Chefs Prepare You for a Healthy Summer
11. This Summer, EyeCare America and Celebrity Chefs Want You to Feast Your Eyes on Eye Healthy Foods
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10Lethality of H1N1 Influenza Virus Increasing According to Latest Replikin Analysis of Virus Peptide Genomic Data 48682 1Lethality of H1N1 Influenza Virus Increasing According to Latest Replikin Analysis of Virus Peptide Genomic Data 48682 2Lethality of H1N1 Influenza Virus Increasing According to Latest Replikin Analysis of Virus Peptide Genomic Data 48682 3AMA Cheers Senate Passage of Historic Tobacco Regulation Bill 48678 1AMA Cheers Senate Passage of Historic Tobacco Regulation Bill 48678 2Anderson ED Team Receives Pinnacle Award for Excellence in Customer Service 48674 1Anderson ED Team Receives Pinnacle Award for Excellence in Customer Service 48674 2Anderson ED Team Receives Pinnacle Award for Excellence in Customer Service 48674 3